Table 1.

Patient and treatment characteristics.

Pt No	Tumor No	Age	Initial Dx	Location of rec	Time to rec (mo)	CTV (cc)	Chemo for rec	Previous XRT	SBRT delivery	Total BED Gy10d	Local control	Survival	Grade 3/4 Tox	F/U (mo)
1	1	58	Ovarian-serous	PSW	28	52.9	No	No	CK only	59.5	LR	Death	No	17
2	2	70	Endometrial	Central	19	29.1	Yes	No	CK boost	81.1	LR	Death	No	15
3	3	83	Endometrial	PA	15	32.8	No	Yes	CK only	35.7	LC	Death	No	6
4	4	82	Endometrial	PA	38	12.7	Yes	No	CK only	72	LC	Alive	No	92
5	5	80	Cervical	PSW	3	0.91	No	No	CK boost	112.8	LC	Death	No	19
6	6	40	Cervical	Central	28	9.4	Yes	No	CK boost	83.7	LC	Alive	No	24
7	7	72	Cervical	Central	78	29.8	Yes	No	CK boost	90.6	LC	Alive	Noa	45
8	8	82	Cervical	Central	507	285.3	No	Yes	CK only	48	LC	Death	No	5
9	9	68	Ovarian-clear cell	PSW	54	30	No	No	CK only	42.6	LC	Death	No	29
10	10	79	Cervical	PSW	15	68.3	No	Yes	CK only	48	LC	Death	No	7
11	11	37	Cervical	Central	29	88.8	Yes	Yes	CK only	37.5	LC	Alive	Yesb	21
12	12	64	Endometrial	PSW	18	8.3	No	No	CK boost	75.6	LC	Alive	Noc	77
13	13	72	Endometrial	PA	6	1.8	No	No	CK boost	81.1	LC	Alive	No	57
14	14	62	Endometrial	PA	3	30.7	No	No	CK only	37.5	LC	Death	No	63
–	15	62	Endometrial	PA	3	8.4	No	No	CK only	37.5	LC	Death	No	–
15	16	71	Cervical	PA	10	8.3	Yes	No	CK only	65.6	LC	Alive	No	63
16	17	70	Endometrial	PA	5	103.5	Yes	No	CK boost	72.6	LC	Alive	No	60
–	18	73	Endometrial	PA	45	7.7	No	Yes	CK only	65.6	LC	Alive	No	–
17	19	76	Carcinosarcoma	Central	14	14.9	No	Yes	CK only	59.5	LR	Alive	No	23
18	20	80	Endometrial	Central	10	85.7	Yes	Yes	CK only	37.5	LC	Death	No	11
19	21	80	Cervical	Central	34	8.3	–	No	CK boost	98	LC	Alive	No	8
20	22	89	Uterine-serous	PA	34	24	No	No	CK only	72	LR	Death	No	16
–	23	89	Uterine-serous	PA	38	8.7	No	No	CK only	48	LR	Death	No	–
21	24	65	Carcinosarcoma	PA	35	31.2	Yes	No	CK only	37.5	LC	Alive	No	22
22	25	60	Uterine-serous	Central	47	50	No	Yes	CK only	48	LR	Death	No	14
–	26	60	Uterine-serous	Central	47	11.4	No	Yes	CK only	48	LR	Death	No	–
23	27	89	Endometrial	PSW	229	38.4	No	Yes	CK only	72	LC	Death	No	43
24	28	79	Endometrial	Central	25	15.7	No	Yes	CK only	59.5	LR	Alive	No	29
25	29	66	Ovarian-serous	PSW	80	4.7	Yes	No	CK only	48	LR	Alive	No	47
26	30	59	Endometrial	PSW	153	43.6	Yes	No	CK boost	81.1	LC	Alive	No	64
27	31	52	Cervical	PSW	3	36.7	No	Yes	CK only	43.2	LC	Death	No	59
–	32	52	Cervical	PSW	3	36.7	No	Yes	CK only	43.2	LC	Death	No	–
28	33	56	Cervical	PA	30	67.3	Yes	Yes	CK only	53.6	LC	Alive	No	17
29	34	60	Endometrial	PSW	98	86.5	Yes	Yes	CK only	48	LC	Alive	No	10
30	35	66	Cervical	PA	21	7.9	No	No	CK only	48	LC	Death	No	26

Pt, patient; No, number; Dx, diagnosis; rec, recurrence; mo, months; CTV, clinical target volume; cc, cubic centimeters; Chemo, chemotherapy; BED, biological equivalent dose; XRT, radiotherapy; Tox, toxicity; PA, para-aortic; PSW, pelvic sidewall; CK, cyberknife; LC, local control; LR, local recurrence; F/U, follow-up.

^aGrade 2 radiation cystitis.

^bGrade 3 rectovaginal/vaginovesicular fistulas.

^cGrade 2 proctitis.

^dIncludes all radiation delivered for recurrence which includes SBRT alone dose or external beam + SBRT combined doses if boost used.

–, unknown if chemotherapy delivered.